Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-03-01 Monahan Joseph Chief Scientific Officer Exercise or conversion +50,000 281,995
2025-03-01 Monahan Joseph Chief Scientific Officer Exercise or conversion +10,925 292,920
2025-03-01 Monahan Joseph Chief Scientific Officer Shares withheld for taxes −27,258 $1.99 $54K 265,662
2025-03-01 Monahan Joseph Chief Scientific Officer Exercise or conversion · Restricted Stock Units −50,000 0
2025-03-01 Monahan Joseph Chief Scientific Officer Exercise or conversion · Restricted Stock Units −10,925 10,925
2025-02-03 Monahan Joseph Chief Scientific Officer Grant or award · Restricted Stock Units +83,900 83,900
2025-02-03 Monahan Joseph Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +293,500 293,500
2025-02-01 Monahan Joseph Chief Scientific Officer Exercise or conversion +7,500 228,562
2025-02-01 Monahan Joseph Chief Scientific Officer Exercise or conversion +14,750 243,312
2025-02-01 Monahan Joseph Chief Scientific Officer Shares withheld for taxes −11,317 $2.48 $28K 231,995
2025-02-01 Monahan Joseph Chief Scientific Officer Exercise or conversion · Restricted Stock Units −7,500 15,000
2025-02-01 Monahan Joseph Chief Scientific Officer Exercise or conversion · Restricted Stock Units −14,750 44,250
2025-01-02 Monahan Joseph Chief Scientific Officer Exercise or conversion +17,380 229,976
2025-01-02 Monahan Joseph Chief Scientific Officer Shares withheld for taxes −8,914 221,062
2025-01-02 Monahan Joseph Chief Scientific Officer Grant or award · Restricted Stock Units +52,667 52,667
2025-01-02 Monahan Joseph Chief Scientific Officer Exercise or conversion · Restricted Stock Units −17,380 35,287
2024-12-31 Monahan Joseph Chief Scientific Officer Exercise or conversion +73,750 245,533
2024-12-31 Monahan Joseph Chief Scientific Officer Shares withheld for taxes −32,937 212,596
2024-12-31 Monahan Joseph Chief Scientific Officer Exercise or conversion · Restricted Stock Units −73,750 73,750
2024-12-10 Monahan Joseph Chief Scientific Officer Gift −15,000 171,783

Page 1 of 4 · 73 trades